EUVIMEDEUVIMED entdecken
Kohortenstudie

Body weight variability and the risk of liver‐related outcomes in type 2 diabetes and steatotic liver disease: a cohort study

Nathalie C Leite iD, Claudia R L Cardoso iD, Cristiane A Villela-Nogueira iD, Gil F Salles iD

Obesity · 2024

DOI: 10.1002/oby.24035 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Obesity, 2024. Verfasst von Nathalie C Leite und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University Hospital Clementino Fraga Filho, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Liver, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development, Carlos Chagas Filho Foundation to Support Research in the State of Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to evaluate the effects of body weight variability (BWV) on the occurrence of adverse liver outcomes in individuals with type 2 diabetes (T2D) and metabolic dysfunction‐associated steatotic liver disease (MASLD).

Methods

A total of 549 patients with T2D and MASLD had BWV parameters assessed during the first 2 years of follow‐up. The associations between increasing BWV and liver outcomes (clinical cirrhosis or a liver stiffness measurement on transient elastography > 15 kPa, performed after a median of 7 years of cohort entry) were examined by multivariable logistic regressions. Interaction/subgroup analyses were performed according to participants' physical activity during the initial 2‐year period.

Results

Individuals were followed up for an additional median 9.7 years, over which 34 liver outcomes occurred (14 with clinical cirrhosis and 20 with liver stiffness measurement > 15 kPa). A 1‐SD increase in weight SD and average real variability was associated with 52% higher (95% CI: 4%–128%) odds of having an adverse liver outcome. Otherwise, in interaction/subgroup analyses, an increased BWV was associated with a higher likelihood of outcomes only in sedentary individuals.

Conclusions

Increased BWV was associated with adverse liver outcomes in individuals with T2D and MASLD; however, in those who were physically active, it was not hazardous.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2LiverFatty LiverHumansMaleFemaleMiddle AgedAgedRisk FactorsLiver CirrhosisCohort StudiesBody WeightElasticity Imaging TechniquesFollow-Up StudiesExerciseBody Mass IndexAdultLogistic Models

Autor:innen und Institutionen

  • Department of Internal Medicine, University Hospital Clementino Fraga Filho, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Nathalie C Leite, Claudia R L Cardoso, Cristiane A Villela-Nogueira, Gil F Salles

Förderung

  • National Council for Scientific and Technological Development
  • Carlos Chagas Filho Foundation to Support Research in the State of Rio de Janeiro
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Leite, N. C., Cardoso, C. R. L., Villela-Nogueira, C. A., & Salles, G. F. (2024). Body weight variability and the risk of liver‐related outcomes in type 2 diabetes and steatotic liver disease: a cohort study. Obesity. https://doi.org/10.1002/oby.24035

Vancouver

Leite NC, Cardoso CRL, Villela-Nogueira CA, Salles GF. Body weight variability and the risk of liver‐related outcomes in type 2 diabetes and steatotic liver disease: a cohort study. Obesity. 2024. doi:10.1002/oby.24035

BibTeX
@article{Leite2024,
  author = {Leite, Nathalie C and Cardoso, Claudia R L and Villela-Nogueira, Cristiane A and Salles, Gil F},
  title = {Body weight variability and the risk of liver‐related outcomes in type 2 diabetes and steatotic liver disease: a cohort study},
  journal = {Obesity},
  year = {2024},
  doi = {10.1002/oby.24035}
}
Kostenlos starten →